The purpose of this study was to analyze characteristics, reasons for transferring, and reasons for discontinuing care among patients defined as lost to follow-up (LTFU) from an antiretroviral therapy (ART) clinic in Nairobi, Kenya.The study used a prospective cohort of patients who participated in a randomized, controlled ART adherence trial between 2006 and 2008.Participants were followed from pre-ART clinic enrollment to 18 months after ART initiation, and were defined as LTFU if they failed to return to clinic 4 weeks after their last scheduled visit. Reasons for loss were captured through phone call or home visit. Characteristics of LTFU who transferred care and LTFU who did not transfer were compared to those who remained in clinic us...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...
Current estimates of retention among HIV-infected patients on antiretroviral therapy (ART) in Africa...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...
OBJECTIVES:The purpose of this study was to analyze characteristics, reasons for transferring, and r...
HIV treatment is life-long, yet many patients travel or migrate for their livelihoods, risking treat...
Losses to Follow-Up from Antiretroviral Therapy (ART) programs remain a challenge in Malawi. The ob...
OBJECTIVES: To understand reasons for lost to follow-up (LTFU) from a community-based antiretroviral...
<div><p>Introduction</p><p>Improved HIV outcomes as a result of expanded antiretroviral therapy (ART...
INTRODUCTION:Improved HIV outcomes as a result of expanded antiretroviral therapy (ART) access is th...
BackgroundUnderstanding patient-reported reasons for lapses of retention in human immunodeficiency v...
OBJECTIVE The retention of patients on antiretroviral therapy (ART) is key to achieving global ta...
BackgroundLoss to follow-up (LTFU) is a term used to classify patients no longer being seen in a cli...
Background: Considerable success has been recorded in the global fight against the human immunodefic...
BACKGROUND: Long term retention of patients on antiretroviral therapy (ART) in Africa's rapidly expa...
Among adults eligible for antiretroviral therapy (ART) in Thyolo (rural Malawi) and Kibera (Nairobi,...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...
Current estimates of retention among HIV-infected patients on antiretroviral therapy (ART) in Africa...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...
OBJECTIVES:The purpose of this study was to analyze characteristics, reasons for transferring, and r...
HIV treatment is life-long, yet many patients travel or migrate for their livelihoods, risking treat...
Losses to Follow-Up from Antiretroviral Therapy (ART) programs remain a challenge in Malawi. The ob...
OBJECTIVES: To understand reasons for lost to follow-up (LTFU) from a community-based antiretroviral...
<div><p>Introduction</p><p>Improved HIV outcomes as a result of expanded antiretroviral therapy (ART...
INTRODUCTION:Improved HIV outcomes as a result of expanded antiretroviral therapy (ART) access is th...
BackgroundUnderstanding patient-reported reasons for lapses of retention in human immunodeficiency v...
OBJECTIVE The retention of patients on antiretroviral therapy (ART) is key to achieving global ta...
BackgroundLoss to follow-up (LTFU) is a term used to classify patients no longer being seen in a cli...
Background: Considerable success has been recorded in the global fight against the human immunodefic...
BACKGROUND: Long term retention of patients on antiretroviral therapy (ART) in Africa's rapidly expa...
Among adults eligible for antiretroviral therapy (ART) in Thyolo (rural Malawi) and Kibera (Nairobi,...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...
Current estimates of retention among HIV-infected patients on antiretroviral therapy (ART) in Africa...
Background. Low retention on combination antiretroviral therapy (cART) has emerged as a threat to th...